Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-26-001064
Filing Date
2026-02-17
Accepted
2026-02-17 15:21:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7060
  Complete submission text file 0000902664-26-001064.txt   8845
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91525 | Film No.: 26640203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111 415-801-4550
Woodline Partners LP (Filed by) CIK: 0001784547 (see all company filings)

EIN.: 831749088 | State of Incorp.: DE
Type: SCHEDULE 13G/A